Baystate Wealth Management LLC - LEAP THERAPEUTICS INC ownership

LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 60 filers reported holding LEAP THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.0%.

Quarter-by-quarter ownership
Baystate Wealth Management LLC ownership history of LEAP THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$5,231
+74628.6%
15,3850.0%0.00%
-100.0%
Q4 2022$7
-100.0%
15,3850.0%0.00%0.0%
Q3 2022$14,000
-22.2%
15,3850.0%0.00%
-50.0%
Q2 2022$18,000
-33.3%
15,3850.0%0.00%0.0%
Q1 2022$27,000
-46.0%
15,3850.0%0.00%
-60.0%
Q4 2021$50,000
-19.4%
15,3850.0%0.01%
-16.7%
Q3 2021$62,00015,3850.01%
Other shareholders
LEAP THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Sio Capital Management, LLC 476,223$533,0000.13%
683 Capital Management, LLC 150,142$168,0000.02%
Alyeska Investment Group, L.P. 514,285$576,0000.01%
Baker Brothers Advisors 978,454$1,096,0000.01%
Quilter Plc 50,000$56,0000.00%
Schonfeld Strategic Advisors LLC 80,319$90,0000.00%
FMR LLC 660,800$740,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Lionsbridge Wealth Management LLC 181$00.00%
GEODE CAPITAL MANAGEMENT, LLC 328,986$368,0000.00%
View complete list of LEAP THERAPEUTICS INC shareholders